This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

PDF
Markdown

2020-09-30-accounts

		Page
Report ofthe Trustees		1 to	5
Report ofthe Independent Auditors		6 to	8
Statement of Financial Activities
Balance Sheet		10 to	11
Notes to the Financial Statements		12 to	19
Detailed Statement of Financial	Activities	20 to	21

Statement of Financial Activities	Statement of Financial Activities
Incor oratin an income and	Ex enditure	Account
for the Year Ended 30Se tember 2020
					30.9.20	30.9.19
			Unrestricted	Restricted	Total	Total
			fund	fund	funds	funds
		Notes	E	E	E	E
INCOME AND ENDOWMENTS Donations and legacies	FROM		7,529	11,355	18,884	22,125
Charitable activities Research into and education	on oncology			37,584	37,584	129,725
Investment income Other income		2	8,064	32,124 1,400	40,188 1,400	46,056 500
Total			15,593	82,463	98,056	198,406
EXPENDITURE ON Raising funds		3	2,658	10,681	13,339	21,037
Charitable activities Research into and education	on oncology		12,273	70,139	82,412	166,634
Total			14,931	80,820	95,751	187,671
Net gains/(losses) on investments			(23,686)	(95,176)	(118,862)	17,208
NET INCOME/(EXPENDITURE)			(23,024)	(93,533)	(116,557)	27,943
RECONCILIATION OF FUNDS
Total funds brought forward			302,461	1,215,400	1,517,861	1,489,918
TOTAL FUNDS CARRIED FORWARD			278427	1121867	14D1~D4	1817861

The Mount Ver ~WT t	non Marie Curie Research
Balance Sheet
~30 3 t 8	2I120
					30.9.20	30.9.19
			Unrestricted	Restncted	Total	Total
			fund	fund	funds	funds
		Notes	f	f	f	f
FIXED ASSETS Investments		10	144,242	967,944	1,112,186	1,231,612
CURRENT ASSETS Debtors Cash at bank		11	2,000 141,700	13,985 142,580	15,985 284,280	12,468 292,715
			143,700	156,565	300,265	305,183
CREDITORS Amounts falling due within one year		12	(8,505)	(2,642)	(11,147)	(18,934)
NET CURRENT	ASSETS		135,195	153,923	289,118	286,249
TOTAL ASSETS LESS CURRENT LIABILITIES			279,437	1,121,867	1,401,304	1,517,861
NET ASSETS			273,437	1,121,867	1,4D1,3D4	1.517,861
FUNDS Unrestricted funds Restricted funds		13			279,437 1,121,867	302,461 1,215,400
TOTALFUNDS					1,4D1,3D4	1,517,861

STAFF	COSTS	30.9.20	30.9.19
		E	f
Wages	and salaries	54,459	135,917
		54,459	135,917

	The average monthly numb	er	of employees	during the year was as follows
	Research staff				30.9.20 2	30.9.19 =2
	There were no employees	with emoluments		over E60,000.
8.	COMPARATIVES FOR THE	STATEMENT OF		FINANCIAL ACTIVITIES Unrestricted	Restricted	Total
				fund	fund	funds
				E	f	f
	INCOME AND ENDOWMENTS Donations and legacies		FROM	11,722	10,403	22,125
	Charitable activities Research into and education		on oncology	10,121	119,604	129,725
	Investment income			8,891	37,165 500	46,056 500
	Otherincome
	Total			30,734	167,672	198,406
	EXPENDITURE ON Raising funds			4,051	16,986	21,037
	Charitable activities Research into and education		on oncology	14,456	152,178	166,634
				18,507	169,164	187,671

o the Financial Statements -continued Year Ended 30Se tember 2020	o the Financial Statements -continued Year Ended 30Se tember 2020	o the Financial Statements -continued Year Ended 30Se tember 2020
COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES -continued Unrestricted			Restricted	Total
	fund		fund	funds
	E		f	E
Net gains on investments	I3 314		13894 P	17,208
NET INCOME	15,541		12,402	27,943
RECONCILIATION OF FUNDS
Total funds brought forward	286,920	1,202,998		1,489,918
TOTAL FUNDS CARRIED FORWARD	302,461	1,215,400		1,517,861

Fighting Breast Cancer	25,085	5,415	(388)	(1,964)	28,148
	302,461	15,593	(14931)	(23,686)	279,437
Restricted
funds
Prof P Hoskin Dr A Makris Dr P Ostler	560,699 100,070 26,302	51,238 2,622 1,276	(40,813) (3,402) (231)	(43,907) (7,836) (2,060)	527,217 91,454 25,287
Dr C Lemon Dr M Harrison Dr N Shah Dr D Miles	211,478 19,742 69,299 105,742	10,778 517 1,816 2,771	(29,127) (173) (409) (3,555)	(16,561) (1,5461 (5,427) (&,280)	176,568 18,540 65,279 96,678
Dr 5 Mawdsley Dr R Alonzi Development	14,552 19,442 72,856	381 3,940 1,909	(128) (1,310) (890)	(1,140) (1,522) (5,705)	13,665 20,550 68,170
Cyberknife Fund	7,482	2,762	(714)	(586)	8,944
Dr Westbury /GuPPY Dr Neel Bhuva	6,465 1.271	169 2,284	(57) (11)	(506) (100)	6,071 3,444
	1,215,400	82,463	(80,820)	(95,176)	1,121,867
TOTAL FUNDS	1,517,861	98,056	(95,751)	(118,862)	1,401,304

The Mount Vernon Marie Curie Research	The Mount Vernon Marie Curie Research
~ltli t t
Detailed Statement of Financial Activities
for the Year Ended 30Se tember 2020		30.9.20	30.9.19
		E	E
INCOME AND ENDOWMENTS
Donations and legacies Donations Legacies		17,884 1,000	20,088 2,037
		18,884	22,125
Investment income Other investment income		40,188	46,056
Charitable activities Grants		37,584	129,725
Other income Training income		1,400	500
Total incoming resources		98,056	198,406
EXPENDITURE
Investment management	costs	13339	21037
Portfolio management
Charitable activities Research salaries Research materials		54,459 1,705 90	135,917 2,554 20
Transport expenses Lecture fees Conference Computer expenses		(110) 6,527 4,412	200 9,979 146
		67,083	148,816
Support costs
Other Subscriptions Administrative expenses Carried forward		1,526 8,288 9,814	1,333 8,796 10,129

Detailed Statement of Financial	Detailed Statement of Financial	Activities
for the Year Ended 30Se	tember 2020		30.9.20	30.9.19
			E	E
Other Brought forward Travelling Student training			9,814 715	10,129 1,203 1,686
			10,529	13,018
Governance costs Auditors' remuneration Auditors' remuneration	for non audit work		3,600 1,200	3,600 1,200
			4,800	4,800
Total resources expended			95,751	187,671
Net income before gains	and losses		2,305	10,735
Realised recognised gains and		losses
Realised gains/(losses) on fixed asset investments			(28,659)	23,867
Net (expenditure)/income			(26,354)	34,602